As previously reported, TP53 mutation was highly enriched in high-grade serous carcinomas (HGSC; 82%), while only 17% of clear cell tumors harbored somatic mutation of TP53 (P = 2.179 × 10−05) [38, 39]. This evidence concerns the gene TP53 and serous adenocarcinoma.